BioCentury
ARTICLE | Clinical News

Aplenzin bupropion hydrobromide regulatory update

April 28, 2008 7:00 AM UTC

FDA approved an NDA from Biovail for once-daily Aplenzin bupropion hydrobromide (formerly BVF-033) to treat depression in adults. Biovail had received a not approvable letter for the compound last Jul...